Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00SQD
|
|||
| Former ID |
DNC001837
|
|||
| Drug Name |
ISIS 112022
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Company |
Isis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | hnRNP A1 messenger RNA (HNRNPA1 mRNA) | Target Info | . | [1] |
| KEGG Pathway | Spliceosome | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| Pathway Interaction Database | Coregulation of Androgen receptor activity | |||
| Reactome | mRNA Splicing - Major Pathway | |||
| WikiPathways | mRNA Processing | |||
| Influenza Life Cycle | ||||
| Processing of Capped Intron-Containing Pre-mRNA | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | US patent application no. 6,165,789, Antisense modulation of hnRNP A1 expression. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.